Immunotherapy using immune cells for cancer fighting is a groundbreaking approach that leverages the body's own immune system to recognize, attack, and eliminate cancer cells. This therapeutic strategy harnesses the power of various immune cells, enhancing their natural ability to detect and destroy malignant cells. W Holdings provides cutting-edge clinical treatments such as stem cell-based therapies, DNA and genome sequencing, as well as a wide array of non-clinical wellness options to promote a balanced and healthier lifestyle.
Natural Killer Cells (NK)
NK cells are a type of lymphocyte that forms a critical component of the innate immune system. Unlike traditional T cells, NK cells do not require prior exposure to antigens to recognize and attack cancer cells. These cells are equipped with the ability to identify and eliminate abnormal cells, including cancerous ones, by releasing cytotoxic granules. NK cells are being harnessed in cancer therapy to enhance the body's natural defense mechanisms and target tumors.
Natural Killer ‘T’ Cells (NKT)
NKT cells bridge the gap between the innate and adaptive immune systems. They possess characteristics of both T cells and NK cells, making them versatile defenders against cancer. NKT cells recognize glycolipid antigens presented by CD1d molecules, allowing them to swiftly respond to tumor cells. NKT cells contribute to immune surveillance and can be activated to unleash potent anti-tumor responses. Researchers are exploring ways to leverage NKT cells in cancer treatment to enhance the specificity and efficacy of immune responses.
CYTOKINE-Induced Killer Cells (NKT)
CIK cells are a specialized subset of T lymphocytes that are generated and expanded in the laboratory. They acquire enhanced anti-tumor activity through the addition of specific cytokines during their cultivation. CIK cells are particularly attractive for cancer therapy due to their potent cytotoxicity against a variety of cancer cell types. In adoptive cell transfer approaches, CIK cells are infused into patients to bolster the immune response against tumors. The adaptability and broad-spectrum targeting ability of CIK cells make them a valuable asset in the fight against cancer.
